Investigating Visual Verticality Disorder and Lateropulsion in a Neurosurgical Cohort of Patients With Brain Tumours

ConditionBrain Tumours
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorThe University of Western Australia

About this trial

The overall objective of this research is to investigate the clinical characteristics pre- and post-brain tumour resection with a focus on visual verticality disorder, and lateropulsion, including neuroimaging analysis, of a neurosurgical cohort of patients with brain tumours. This prospective observational cohort study will investigate clinical and neuroimaging characteristics and the relationship between lateropulsion and visual verticality disorder in patients pre- and post-brain tumour resection. Patients (aged 18-80 years, with a confirmed diagnosis of brain tumour and a neurosurgical pathway) will be enrolled from the state-wide Neurosurgery Service of Western Australia at Sir Charles Gairdner Hospital.

Eligibility criteria

Qualifiers

Patients of age 18 to 80 admitted to SCGH under the neurosurgery team with a confirmed diagnosis of a brain tumour.

Only patients who undergo partial or full brain tumour resection and are medically stable.

Able to provide written informed consent or consent provided by a Research Decision-Maker with the approval of an Independent Medical Practitioner (IMP) as per the Guardianship and Administration Act 1990 (GAA).

Patients with a support network that enables them to accommodate to travel commitments for assessments if travel to the hospital is required.

Disqualifiers

Patients who undergo only biopsy will not be included.

Unable to follow any instructions and complete assessments due to significant medical deterioration.

Patients who are pregnant.

Current diagnosis of COVID-19 or respiratory syncytial virus (RSV), or any type of influenza.

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

100 Participants
are grouped into 1 trial group

Sponsors and collaborators

The University of Western Australia

Lead sponsor

Sir Charles Gairdner Hospital

Collaborator

University of Sao Paulo

Collaborator